Lennox-Gastaut is a dubious disease in the field of the nervous system, with complex clinical outcomes that often involve multi-system burden. Early identification and standardized clinical care are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory testing and pathological activation.
The platform can help align national and international authorities with teams to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system disorders that have previously been difficult to treat have improved significantly. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Lennox-Gastaut. The platform serves a team of authoritative experts at home and abroad in the field of China's International Medical Service System for Neurosystem Matching, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.